Trial Profile
A randomised, placebo controlled, double blind study to evaluate the effect of 300mcg testosterone patches in addition to HRT on arterial compliance, insulin resistance and sexual desire.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Menopausal syndrome
- Focus Pharmacodynamics
- 18 Jul 2019 Status changed from recruiting to completed.
- 29 Sep 2010 New trial record